Share-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2007
Weighted Average Fair Value [Roll Forward]        
Total unrecognized compensation cost related to nonvested share-based compensation $ 6,785      
Cost is expected to be recognized over a weighted average period 1 year 7 days      
Stock Options [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting periods in equal annual installments 3 years      
Number of Shares [Roll Forward]        
Outstanding balance, beginning of period (in shares) 4,440      
Exercised during the year (in shares) (4,440) (12,913) (199,002)  
Outstanding balance, end of period (in shares) 0 4,440    
Exercisable, end of period (in shares) 0      
Weighted Average Exercise Price [Roll Forward]        
Outstanding balance, beginning of period (in dollars per share) $ 12.49      
Exercised during the year (in dollars per share) 12.49      
Outstanding balance, end of period (in dollars per share) 0 $ 12.49    
Exercisable, end of period (in dollars per share) $ 0      
Aggregate Intrinsic Value [Abstract]        
Outstanding balance, end of period $ 0      
Exercisable, end of period $ 0      
Stock option grant in period (in shares) 0 0 0  
Cash received from stock options exercises $ 0 $ 0    
Number of shares repurchased and retired as a result of non-cash exercise of stock options (in shares) 2,290 7,235 174,090  
Stock Options [Member] | Maximum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expiration date cannot exceed 7 years      
Restricted Awards [Member]        
Number of Shares [Roll Forward]        
Outstanding balance, beginning of period (in shares) 156,331      
Granted (in shares) 110,181      
Lapsed (in shares) (99,276)      
Forfeited (due to termination) (in shares) (5,412)      
Forfeited (due to performance payout less than 100%) (in shares) 0      
Outstanding balance, end of period (in shares) 161,824 156,331    
Weighted Average Fair Value [Roll Forward]        
Outstanding balance, beginning of period (in dollars per share) $ 19.45      
Granted (in dollars per share) 23.78 $ 20.33 $ 16.46  
Lapsed (in dollars per share) 20.14      
Forfeited (due to termination) (in dollars per share) 20.27      
Forfeited (due to performance payout less than 100%) (in dollars per share) 0      
Outstanding balance, end of period (in dollars per share) $ 21.94 $ 19.45    
Total fair value of restricted stock vested $ 2,335 $ 3,608 $ 1,146  
Restricted Awards [Member] | Minimum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting periods in equal annual installments 1 year      
Restricted Awards [Member] | Maximum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting periods in equal annual installments 3 years      
Performance Awards [Member]        
Number of Shares [Roll Forward]        
Outstanding balance, beginning of period (in shares) 495,005      
Granted (in shares) 234,121      
Lapsed (in shares) (89,171)      
Forfeited (due to termination) (in shares) (60,218)      
Forfeited (due to performance payout less than 100%) (in shares) (121,542)      
Outstanding balance, end of period (in shares) 458,195 495,005    
Weighted Average Fair Value [Roll Forward]        
Outstanding balance, beginning of period (in dollars per share) $ 17.84      
Granted (in dollars per share) 23.85      
Lapsed (in dollars per share) 16.17      
Forfeited (due to termination) (in dollars per share) 16.67      
Forfeited (due to performance payout less than 100%) (in dollars per share) 18.61      
Outstanding balance, end of period (in dollars per share) $ 21.44 $ 17.84    
2007 Incentive Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares authorized under the plan (in shares)       4,700,000
Shares available to grant under the plan (in shares) 1,333,093 1,677,395